Improves access to lower-cost generic and biosimilar drugs.

Summary

The bill tells Medicaid‑managed health plans to list any approved generic or biosimilar that costs less than the brand version and to give it cheaper out‑of‑pocket pricing. It also forces plans to publish their drug lists online in a way anyone can see without logging in. The goal is to make cheaper, FDA‑approved medicines more available to patients.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share